PhaseBio Pharmaceuticals (PHAS.Q), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary disease, announced today that it has entered into an exclusive licensing…
Latest News
Standard Uranium (STND.V) reports on exploration at Sun Dog Project
Top 5 Gainers and Losers: BLO.CN, DKL.V, MMG.V
Bitcoin bulls beware! Topping pattern to trigger more downside?
Top 5 Gainers and Losers: NUMI.TO, FOBI.V, IDK.CN
Top 5 Gainers and Losers: COR.V, PGDC.V, LOT.V
Atco Mining and Standard Uranium show promising early uranium drill results